Serviços Personalizados
Journal
Artigo
Indicadores
- Citado por SciELO
- Acessos
Links relacionados
- Citado por Google
- Similares em SciELO
- Similares em Google
Compartilhar
Acta Neurológica Colombiana
versão impressa ISSN 0120-8748versão On-line ISSN 2422-4022
Resumo
MORENO VARGAS, Eder A. et al. Cost analysis of in hospital attention in a non-valvular atrial fibrillation patient and recurrent stroke. Acta Neurol Colomb. [online]. 2022, vol.38, n.3, pp.139-147. Epub 22-Out-2022. ISSN 0120-8748. https://doi.org/10.22379/24224022419.
INTRODUCTION:
A 71-year-old patient with a diagnosis of atrial fibrillation and recurrent strokes, treated with various anticoagulants, the stroke treatment in Colombia for 2008 was $ 450 billion Colombian pesos.
OBJECTIVE:
To estimate the hospital cost of caring for a patient with recurrent stroke secondary to atrial fibrillation.
METHODS:
Partial economic study of micro costing of in-hospital care for a case of recurrent severe spectrum stroke, which does not necessarily reflect the average case. Resource consumption was valued using national reference rates. The results are presented in current 2019 prices (Colombian pesos and US dollars).
RESULTS:
Patient with 3 hospital events, who was hospitalized for 31 days. Hospitalizations had costs of $ 53,883,490 (USD 16,141.1), $ 6,343,096 (USD 1,900.1) and $ 15,719,443 (USD 4,708.9) respectively, with an average price for each hospitalization of $ 25,315,343 (USD 7,583.4), total cost of $ 75,946,029 (USD 22,750.1) daily cost of $ 2,449,872 (USD 729.5). The item that consistently increased costs was procedures (35.7 %).
CONCLUSIONS:
Recurrent stroke caused by nonvalvular atrial fibrillation is associated with a significant increase in direct costs, with an impact of almost twice the GDP per capita. A timely diagnosis and proper selection can reduce it.
Palavras-chave : Stroke; Atrial fibrillation; Costs and cost analysis; Anticoagulants; Economics, medical (MeSH).